Alto Neuroscience (ANRO) Research & Development (2023 - 2026)

Alto Neuroscience (ANRO) has 4 years of Research & Development data on file, last reported at $20.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development rose 103.47% year-over-year to $20.3 million; the trailing twelve-month figure through Mar 2026 stood at $55.9 million (up 18.97% YoY), and the FY2025 full-year result was $45.6 million, down 2.93% from the prior year.
• Research & Development grew to $20.3 million in Q1 2026, from $12.0 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $20.3 million in Q1 2026 to a low of -$20.4 million in Q4 2023.
• A 4-year average of $8.7 million and a median of $10.5 million in 2025 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 152.82% in 2024 and decreased 19.41% in 2025, its largest moves.
• Tracing ANRO's Research & Development over 4 years: stood at -$20.4 million in 2023, then surged by 152.82% to $10.8 million in 2024, then advanced by 11.07% to $12.0 million in 2025, then surged by 69.17% to $20.3 million in 2026.
• Business Quant data shows ANRO's Research & Development at $20.3 million in Q1 2026, $12.0 million in Q4 2025, and $10.5 million in Q3 2025.